The next board meeting for Stoke Therapeutics Inc is on 25 Mar 2025 for the purpose of Stoke Therapeutics Inc Fourth Quarter Earnings Results for 2024See details
Stoke Therapeutics Inc has a share price target of US$ 24, revenue growth forecast of 131.7%, and profit growth estimate of 43.2% for FY25, based on top 10 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature